JNJ — Johnson & Johnson Share News
0.000.00%
Last trade - 00:00- $610.38bn
- $638.66bn
- $94.19bn
U.S. STOCKS ON THE MOVE-AI stocks, energy companies, Johnson & Johnson
U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & Johnson
J&J gains after report says Apollo in talks for company's orthopedics unit
Brief: J&J Says Rybrevant Plus Chemotherapy Delivers Longest Reported Median Overall Survival In EGFR Exon 20 Insertion NSCLC
J&J orthopedics unit draws Apollo interest in potential $20 billion deal, Bloomberg News reports (updated)
Apollo Global in talks to acquire J&J's orthopedics unit, Bloomberg News reports
Brief: Apollo Global Is Said In Talks To Acquire J&J’s Orthopedics Unit - Bloomberg News
Live Markets: Wall Street starts slow, Dow leads
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
China approves J&J psoriasis pill Icotyde, says drugmaker (updated)
China approves J&J's oral psoriasis pill, says drugmaker
Brief: FDA Issues Early Alert On Abiomed Heart Pump Controller Purge Cassette Issue
Refile: UPDATE 1-US FDA expands approval for J&J's drug for rare blood disorder
US FDA expands approval for J&J's drug for rare blood disorder
Johnson & Johnson names new vice president for litigation
Three scientists beat J&J's defamation suit over talc research
Brief: J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3
US FDA approves Bristol Myers' blood cancer treatment (updated)